TRCT
IHE icon

Tower Research Capital (TRC)’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.19M Buy
18,116
+3,728
+26% +$244K 0.03% 475
2025
Q1
$1.02M Buy
+14,388
New +$1.02M 0.03% 492
2024
Q4
Sell
-4,012
Closed -$283K 5829
2024
Q3
$283K Buy
4,012
+3,207
+398% +$226K 0.01% 1304
2024
Q2
$53.4K Sell
805
-5,613
-87% -$372K ﹤0.01% 3055
2024
Q1
$436K Sell
6,418
-36,939
-85% -$2.51M 0.01% 942
2023
Q4
$8.04M Buy
43,357
+41,480
+2,210% +$7.69M 0.1% 161
2023
Q3
$332K Sell
1,877
-60
-3% -$10.6K 0.01% 1119
2023
Q2
$347K Sell
1,937
-118
-6% -$21.1K 0.01% 1205
2023
Q1
$360K Buy
2,055
+1,467
+249% +$257K 0.01% 1026
2022
Q4
$109K Sell
588
-3,575
-86% -$663K ﹤0.01% 1766
2022
Q3
$706K Sell
4,163
-11,935
-74% -$2.02M 0.01% 889
2022
Q2
$3.09M Buy
16,098
+14,200
+748% +$2.72M 0.07% 234
2022
Q1
$369K Buy
+1,898
New +$369K ﹤0.01% 1333
2021
Q4
Sell
-685
Closed -$125K 6335
2021
Q3
$125K Buy
+685
New +$125K ﹤0.01% 2206
2021
Q2
Sell
-2,397
Closed -$426K 5639
2021
Q1
$426K Sell
2,397
-34,915
-94% -$6.21M 0.01% 1372
2020
Q4
$6.7M Buy
37,312
+34,694
+1,325% +$6.23M 0.2% 46
2020
Q3
$428K Sell
2,618
-5,889
-69% -$963K ﹤0.01% 1855
2020
Q2
$1.31M Buy
+8,507
New +$1.31M 0.05% 375
2019
Q4
Sell
-378
Closed -$53K 3903
2019
Q3
$53K Sell
378
-7,024
-95% -$985K ﹤0.01% 1759
2019
Q2
$1.12M Sell
7,402
-2,566
-26% -$387K 0.08% 236
2019
Q1
$1.54M Buy
+9,968
New +$1.54M 0.09% 169
2018
Q4
Sell
-2,968
Closed -$498K 4056
2018
Q3
$498K Sell
2,968
-477
-14% -$80K 0.04% 477
2018
Q2
$521K Buy
+3,445
New +$521K 0.03% 627
2016
Q1
Sell
-30,476
Closed -$4.93M 4499
2015
Q4
$4.93M Sell
30,476
-2,215
-7% -$358K 0.8% 12
2015
Q3
$4.84M Buy
32,691
+24,203
+285% +$3.58M 0.47% 22
2015
Q2
$1.48M Buy
8,488
+3,515
+71% +$615K 0.13% 69
2015
Q1
$857K Sell
4,973
-2,302
-32% -$397K 0.11% 121
2014
Q4
$1.1M Sell
7,275
-17,775
-71% -$2.69M 0.11% 90
2014
Q3
$3.52M Buy
25,050
+16,579
+196% +$2.33M 0.39% 44
2014
Q2
$1.14M Sell
8,471
-29,163
-77% -$3.94M 0.15% 78
2014
Q1
$4.77M Buy
37,634
+33,350
+778% +$4.23M 0.61% 26
2013
Q4
$506K Buy
+4,284
New +$506K 0.08% 180